Altered plasma acylcarnitine and amino acid profiles in type 2 diabetic kidney disease
Conclusions
The findings suggest that plasma C4 may serve as a potential biomarker for the early stages of DN.
Source: Metabolomics - Category: Biology Source Type: research
More News: Biology | Cholesterol | Diabetes | Diabetes Type 2 | Endocrinology | Study | Urology & Nephrology